[Clinical effect of L-DOPA and electromyographic study of Parkinsonism].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004576:Electromyography; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
D004295:Dihydroxyphenylalanine